期刊文献+

^(131)I治疗格雷夫斯病剂量确定方法的探讨

Discussion on the dose-determination schemes of ^(131)I therapy of Graves'disease
原文传递
导出
摘要 ^(131)I治疗格雷夫斯病(GD)的疗效和安全性等已得到国内外学者认可,但对具体治疗剂量的选择仍然存在一定争议。治疗目标不同,剂量选择方案也不同。国内学者多选择计算剂量法与个体化相结合的方案,国外学者多选择固定剂量方案。笔者就国内外 ^(131)I治疗GD的剂量确定方法作一综述。 The curative efficacy and safety of the ^(131)I therapy of Graves'disease have been recognized by most domestic and international scholars,but the choice of the specific therapeutic dose is still controversial.According to different therapeutic targets,the choice of the dose-determination scheme is also different.Domestic scholars mostly choose the combination of calculated dose method individualized scheme,while foreign scholars mostly choose the fixed dose scheme.This article reviews the dose-determination schemes of ^(131)I therapy for Graves'disease.
作者 张晗玉 段炼 Zhang Hanyu;Duan Lian(Major of Imaging Medicine and Nuclear Medicine,Graduate School of Changzhi Medical College,Changzhi 046000,China;Department of Nuclear Medicine,Heping Hospital Affiliated to Changzhi Medical College,Changzhi 046000,China)
出处 《国际放射医学核医学杂志》 2021年第11期721-727,共7页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 格雷夫斯病 甲状腺功能亢进症 碘放射性同位素 治疗剂量 Graves disease Hyperthyroidism Iodine radioisotopes Therapeutic dosage
  • 相关文献

参考文献7

二级参考文献101

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部